Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model

被引：0
|
作者：
Ochoa-Callejero, Laura [1 ]
Perez-Martinez, Laura [1 ]
Rubio-Mediavilla, Susana [2 ]
Oteo, Jose A. [1 ]
Martinez, Alfredo [1 ]
Blanco, Jose R. [1 ]
机构：
[1] Ctr Biomed Res La Rioja CIBIR, Logrono, Spain
[2] Hosp San Pedro, Logrono, Spain
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-LB-173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-173
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
    Ochoa-Callejero, Laura
    Perez-Martinez, Laura
    Rubio-Mediavilla, Susana
    Oteo, Jose A.
    Martinez, Alfredo
    Blanco, Jose R.
    [J]. PLOS ONE, 2013, 8 (01):
  • [2] MARAVIROC, A CCR5 ANTAGONIST, PREVENTS DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN A MOUSE MODEL
    Ochoa-Callejero, L.
    Perez, L.
    Rubio, S.
    Oteo, J. A.
    Martinez, A.
    Blanco, J. R.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S437 - S437
  • [3] Maraviroc: a new CCR5 antagonist
    Sayana, Shilpa
    Khanlou, Homayoon
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (01) : 9 - 19
  • [4] Maraviroc, a CCR5 antagonist, prevents the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
    Perez-Martinez, L.
    Perez-Matute, P.
    Aguilera-Lizarraga, J.
    Rubio, S.
    Narro, J.
    Ochoa-Callejero, L.
    Oteo, J. A.
    Blanco, J. R.
    [J]. ANTIVIRAL THERAPY, 2013, 18 : A69 - A69
  • [5] Treatment of HIV infection with the CCR5 antagonist maraviroc
    Kromdijk, Wiete
    Huitema, Alwin D. R.
    Mulder, Jan Willem
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1215 - 1223
  • [6] Maraviroc - The first CCR5 antagonist for the treatment of HIV
    Girotto, Jennifer E.
    [J]. FORMULARY, 2007, 42 (10) : 601 - 608
  • [7] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
  • [8] Study of intracellular and immunomodulant effects of CCR5 Antagonist Maraviroc
    Sauzullo, I.
    Mengoni, F.
    Rossi, R.
    Celardo, I.
    Ghibelli, L.
    Lichtner, M.
    Massetti, A. P.
    Mastroianni, C. M.
    Vullo, V.
    [J]. INFECTION, 2010, 38 : 92 - 93
  • [9] Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
    Price, David A.
    Armour, Duncan
    de Groot, Marcel
    Leishman, Derek
    Napier, Carolyn
    Perros, Manos
    Stammen, Blanda L.
    Wood, Anthony
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4633 - 4637
  • [10] Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc
    Asano, Shigehiro
    Gavrilyuk, Julia
    Burton, Dennis R.
    Barbas, Carlos F., III
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (02): : 133 - 137
12345